Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Anemia

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 39 articles:
HTML format



Single Articles


    July 2024
  1. MEULENBELD A, Ramondt S, Sweegers MG, Quee FA, et al
    Effectiveness of ferritin-guided donation intervals in whole-blood donors in the Netherlands (FIND'EM): a stepped-wedge cluster-randomised trial.
    Lancet. 2024;404:31-43.
    PubMed     Abstract available


    May 2024
  2. PASRICHA SR, Rogers L, Branca F, Garcia-Casal MN, et al
    Measuring haemoglobin concentration to define anaemia: WHO guidelines.
    Lancet. 2024;403:1963-1966.
    PubMed    


    April 2024
  3. D'ANGELO SP, Araujo DM, Abdul Razak AR, Agulnik M, et al
    Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
    Lancet. 2024;403:1460-1471.
    PubMed     Abstract available


    January 2024
  4. WEST EE, Woodruff T, Fremeaux-Bacchi V, Kemper C, et al
    Complement in human disease: approved and up-and-coming therapeutics.
    Lancet. 2024;403:392-405.
    PubMed     Abstract available


    December 2023
  5. THE LANCET
    The promise of genetic therapies in sickle cell disease.
    Lancet. 2023;402:2265.
    PubMed    


    November 2023
  6. BRADFORD DRR, Swift A, Allik M, McMahon AD, et al
    Physical health of care-experienced young children in high-income countries: a scoping review.
    Lancet. 2023;402 Suppl 1:S28.
    PubMed     Abstract available


    September 2023
  7. ROBERTS I, Jones CP
    Structural racism and iron deficiency anaemia.
    Lancet. 2023;402:834-835.
    PubMed    


    July 2023
  8. AGARWAL N, Azad AA, Carles J, Fay AP, et al
    Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial.
    Lancet. 2023;402:291-303.
    PubMed     Abstract available


  9. DASHRAATH P, Lim KMX, Chin HL, Sidek A, et al
    Non-immune hydrops fetalis caused by Diamond-Blackfan anaemia and a mutation of the RPL15 gene.
    Lancet. 2023;402:141.
    PubMed    


    June 2023
  10. PLATZBECKER U, Della Porta MG, Santini V, Zeidan AM, et al
    Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
    Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874.
    PubMed     Abstract available


    May 2023
  11. CONRAD N, Misra S, Verbakel JY, Verbeke G, et al
    Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK.
    Lancet. 2023 May 5:S0140-6736(23)00457-9. doi: 10.1016/S0140-6736(23)00457.
    PubMed     Abstract available


    April 2023
  12. SHAND AW, Kidson-Gerber GL
    Anaemia in pregnancy: a major global health problem.
    Lancet. 2023 Apr 20:S0140-6736(23)00396-3. doi: 10.1016/S0140-6736(23)00396.
    PubMed    


  13. PASRICHA SR, Mwangi MN, Moya E, Ataide R, et al
    Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
    Lancet. 2023 Apr 20:S0140-6736(23)00278-7. doi: 10.1016/S0140-6736(23)00278.
    PubMed     Abstract available


  14. PEPE J, Cipriani C, Colangelo L, Minisola S, et al
    Avascular necrosis in both hips in a patient with transfusion dependent beta-thalassaemia.
    Lancet. 2023;401:e19.
    PubMed    


    January 2023
  15. VERSTOVSEK S, Gerds AT, Vannucchi AM, Al-Ali HK, et al
    Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
    Lancet. 2023;401:269-280.
    PubMed     Abstract available


  16. IKEDA K, Ueda K
    Gaining MOMENTUM against anaemic myelofibrosis.
    Lancet. 2023;401:248-249.
    PubMed    


    November 2022
  17. MICHAEL M, Bagga A, Sartain SE, Smith RJH, et al
    Haemolytic uraemic syndrome.
    Lancet. 2022;400:1722-1740.
    PubMed     Abstract available


  18. MCDONAGH TA, Bromage DI, Cannata A
    Intravenous iron passes another endurance test in heart failure.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02180.
    PubMed    


  19. KALRA PR, Cleland JGF, Petrie MC, Thomson EA, et al
    Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02083.
    PubMed     Abstract available


    October 2022
  20. SHIH MY, Wang JD
    Ghost cells are the spectre of fetal-maternal haemorrhage.
    Lancet. 2022;400:1223.
    PubMed    


    September 2022
  21. VAN GALEN LS, Simsek S
    Chilling to the marrow: finding extramedullary haematopoiesis in an unusual location behind the xiphoid.
    Lancet. 2022;400:e9.
    PubMed    


    August 2022
  22. KUO KHM, Layton DM, Lal A, Al-Samkari H, et al
    Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent alpha-thalassaemia or beta-thalassaemia: an open-label, multicentre, phase 2 study.
    Lancet. 2022;400:493-501.
    PubMed     Abstract available


  23. KATTAMIS A
    An energy booster for thalassaemic red blood cells.
    Lancet. 2022;400:470-471.
    PubMed    


    June 2022
  24. KATTAMIS A, Kwiatkowski JL, Aydinok Y
    Thalassaemia.
    Lancet. 2022;399:2310-2324.
    PubMed     Abstract available


    January 2022
  25. TONELLI M, Thadhani R
    Anaemia in chronic kidney disease: what do new generation agents offer?
    Lancet. 2022 Jan 25. pii: S0140-6736(22)00120.
    PubMed    


  26. VIGNESHWARAN J, Kumar MS, Raghavan V, Sundari S, et al
    Seizures and sideroblastic anaemia in a patient with multidrug-resistant tuberculosis.
    Lancet. 2022;399:393.
    PubMed    


    September 2021
  27. LICHTSINN HS, Weyand AC, McKinney ZJ, Wilson AM, et al
    Sickle cell trait: an unsound cause of death.
    Lancet. 2021;398:1128-1129.
    PubMed    


  28. GURNARI C, Colak C, Zawit M, Maciejewski JP, et al
    Chronic Budd-Chiari syndrome in paroxysmal nocturnal haemoglobinuria.
    Lancet. 2021;398:e14.
    PubMed    


    February 2021
  29. RICHARDS T, Clevenger B, Dahly D, Besser M, et al
    Iron deficiency in PREVENTT - Authors' reply.
    Lancet. 2021;397:670.
    PubMed    


  30. KEEGAN A, Crispin P, Ormerod A, Brown K, et al
    Iron deficiency in PREVENTT.
    Lancet. 2021;397:669.
    PubMed    


  31. FROESSLER B, Murphy E, Hodyl N
    Iron deficiency in PREVENTT.
    Lancet. 2021;397:668.
    PubMed    


  32. HOFMANN A, Gross I, Girelli D, Aapro M, et al
    Iron deficiency in PREVENTT.
    Lancet. 2021;397:668-669.
    PubMed    


    January 2021
  33. PASRICHA SR, Tye-Din J, Muckenthaler MU, Swinkels DW, et al
    Iron deficiency.
    Lancet. 2021;397:233-248.
    PubMed     Abstract available


  34. GUILLAUME M, Lahary A, Zourdani L, Malandain E, et al
    A painless, sudden loss of vision in sickle cell anaemia: central retinal artery occlusion.
    Lancet. 2021;397:e1.
    PubMed    


  35. CRITCHLEY HOD, Munro MG, Shakur-Still H, Roberts I, et al
    Menstruation should not be overlooked in control of anaemia.
    Lancet. 2021;397:26.
    PubMed    


    December 2020
  36. MUNOZ M, Gomez-Ramirez S, Rondinelli MB, Weltert L, et al
    Preoperative intravenous iron for cardiac surgery.
    Lancet. 2020;396:1884.
    PubMed    


  37. MYLES PS, Richards T, Klein A
    Preoperative intravenous iron for cardiac surgery.
    Lancet. 2020;396:1883-1884.
    PubMed    


    November 2020
  38. PONIKOWSKI P, Kirwan BA, Anker SD, McDonagh T, et al
    Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
    Lancet. 2020 Nov 12. pii: S0140-6736(20)32339.
    PubMed     Abstract available


    September 2020
  39. ABRAMSON JS, Palomba ML, Gordon LI, Lunning MA, et al
    Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study.
    Lancet. 2020;396:839-852.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.